Development of novel vaccine candidates and challenge models for Plasmodium vivax

Development of novel vaccine candidates and challenge models for Plasmodium vivax

Plasmodium vivax is the most widely distributed human malaria parasite in the world and despite nearly 2.5 billion people living at risk, only four vaccines have been assessed in phase I clinical trials and only one has progressed to a phase II trial showing no sterile efficacy. We started to develo...

Full description

Bibliographic Details
Main Authors:	Alves, E, Salman, A, Janse, C, Khan, S, Hill, A, Reyes-Sandoval, A
Format:	Journal article
Published:	BioMed Central 2014

Similar Items

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
by: Alves, E, et al.
Published: (2017)

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
by: Alba Marina Gimenez, et al.
Published: (2021-09-01)

Plasmodium vivax malaria vaccines: why are we where we are?
by: Reyes-Sandoval, A, et al.
Published: (2013)

The challenges of Plasmodium vivax human malaria infection models for vaccine development
by: Roobsoong, W, et al.
Published: (2023)

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models
by: Salman, A, et al.
Published: (2017)

The challenges of Plasmodium vivax human malaria infection models for vaccine development
by: Wanlapa Roobsoong, et al.
Published: (2023-01-01)

Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates.
by: Justin Nicholas, et al.
Published: (2023-09-01)

Genetic diversity and population structure of genes encoding vaccine candidate antigens of <it>Plasmodium vivax</it>
by: Chenet Stella M, et al.
Published: (2012-03-01)

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine
by: Longley, R, et al.
Published: (2016)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
by: Marin-Mogollon, C, et al.
Published: (2018)

Platform for Plasmodium vivax vaccine discovery and development
by: Sócrates Herrera Valencia, et al.
Published: (2011-08-01)

Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
by: Yukiko Miyazaki, et al.
Published: (2020-12-01)

Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors
by: Atcheson, E, et al.
Published: (2018)

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
by: Atcheson, E, et al.
Published: (2020)

Antigenic repertoire of <it>Plasmodium vivax </it>transmission-blocking vaccine candidates from the Indian subcontinent
by: Dua Virendra K, et al.
Published: (2011-05-01)

Plasmodium vivax antigen candidate prediction improves with the addition of Plasmodium falciparum data
by: Renee Ti Chou, et al.
Published: (2024-11-01)

Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes.
by: Lisa H Verzier, et al.
Published: (2019-06-01)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
by: Catherin Marin-Mogollon, et al.
Published: (2018-08-01)

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
by: Bauza, K, et al.
Published: (2014)

Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China
by: Hui Feng, et al.
Published: (2015-12-01)

Challenges in the Control and Elimination of Plasmodium vivax Malaria
by: Asih, P, et al.
Published: (2018)

Genetic structure of <it>Plasmodium vivax </it>and <it>Plasmodium falciparum </it>in the Bannu district of Pakistan
by: Malik Salman A, et al.
Published: (2010-04-01)

Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Kohat District, Pakistan
by: Lubna Khatoon, et al.

Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Kohat District, Pakistan
by: Lubna Khatoon, et al.
Published: (2012-03-01)

Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development.
by: Taís Nóbrega de Sousa, et al.
Published: (2011-01-01)

A library of Plasmodium vivax recombinant merozoite proteins reveals new vaccine candidates and protein-protein interactions
by: Hostetler, JB, et al.
Published: (2015)

Genetic polymorphisms of Plasmodium vivax transmission-blocking vaccine candidates Pvs48/45 and Pvs47 in Thailand
by: Jiraporn Kuesap, et al.
Published: (2025-02-01)

A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
by: Jessica B Hostetler, et al.
Published: (2015-12-01)

Allelic variations in putative antimalarial drug resistance and vaccine candidate genes among Plasmodium vivax reference genomes
by: Suman Tamang, et al.
Published: (2025-02-01)

Towards an effective vaccine against Plasmodium vivax malaria
by: Rawlinson, T
Published: (2018)

Plasmodium vivax vaccine: What is the best way to go?
by: Gisele Tatiane Soares da Veiga, et al.
Published: (2023-01-01)

Towards a vaccine against Plasmodium vivax malaria.
by: James G Beeson, et al.
Published: (2007-12-01)

Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax
by: Gabriela Levitus, et al.
Published: (1994-01-01)

Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection.
by: Ricardo A Chaurio, et al.
Published: (2016-06-01)

The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
by: Ramjanee, S, et al.
Published: (2007)

Epidemiology of Plasmodium vivax in Indonesia
by: Baird, J, et al.
Published: (2016)

N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
by: Fernanda G. Versiani, et al.
Published: (2013-01-01)

Plasmodium vivax susceptibility to ferroquine.
by: Leimanis, M, et al.
Published: (2010)

Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
by: Camila Tenorio França, et al.
Published: (2017-09-01)

Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax.
by: Anjali Yadava, et al.
Published: (2017-01-01)